[ET Net News Agency, 8 March 2023] ALPHAMAB-B (09966) fell 10.03% to HK$13.46, dipping
below the 50-D SMA of HK$13.607.
It hits an intra-day low of HK$13.46, and an intra-day high of HK$14.96. The total
shares traded was 11.56 million, with a value of HK$160.77m. The active buy/sell ratio is
48:52, with net selling turnover of HK$6.57m. CHINA INNOVATION MARKET SER accounts for
greatest net responsive buying turnover of HK$11.02m, with volume weighted average price
of HK$13.945. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover
of HK$7.04m, with volume weighted average price of HK$13.927. The stock has fallen a
combined 13.05% over the past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 13.460 % Chg -10.03%
High 14.960 Low 13.460
Shares Tr 11.56m Turnover 160.77m
10-D SMA 14.670 %H.V 63.108
20-D SMA 14.653 VWAP 13.911
50-D SMA 13.607 RSI14 44.268
----------------------------------
Status: Dipping below the 50-D SMA, active buy/sell ratio is 48:52, with net selling
turnover of HK$6.57m, falling a combined 13.05% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALPHAMAB-B (09966) 13.46 -10.03
ALI HEALTH (00241) 5.67 -2.91
SINO BIOPHARM (01177) 4.22 -0.94
INNOVENT BIO (01801) 39.80 -5.80
JXR (01951) 5.65 -7.22
WUXI BIO (02269) 53.05 -4.67
HYGEIA HEALTH (06078) 59.65 -3.01
JD HEALTH (06618) 56.65 -3.74
ASCENTAGE-B (06855) 22.25 -6.32
AKESO-B (09926) 39.95 -5.22
---------------------------------------------
(ed)